Public notification · FDA Health Fraud Product Database
Lipodrene w/25mg Ephedra Extract Dietary Supplement: FDA Public Notification (May 12, 2021) Agency action: May 12, 2021 Record ID: 3750927d23e8bfeec9788ab79ea6d331af32697f
View official source ↗ What happened Original notice title
Lipodrene w/25mg Ephedra Extract Dietary Supplement
From the archived source record
Presence of 1,4-dimethylamylamine (DMAA)
What the official notice says to do Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice → Status and source details
Status recorded in the archive Recall
Source checked Jul 16, 2026
Record revision c485007a2b4f This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage → What is affected Product Lipodrene w/25mg Ephedra Extract Dietary Supplement Company Hi-Tech Pharmaceuticals. Inc Lot / identifier The source does not specify this field. Market / distribution The source does not specify this field. What is affected Product Lipodrene w/25mg Ephedra Extract Dietary Supplement Company Hi-Tech Pharmaceuticals. Inc Lot / identifier The source does not specify this field. Market / distribution The source does not specify this field. 